EUVIMEDEUVIMED entdecken
Open Access

Colorectal Cancer Prognosis: The Impact of Signet Ring Cell

Refik Bademci, Jesus Bollo, M Carmen Martinez, Maria Pilar Hernadez, Eduardo Maria Targarona

Gastrointestinal Tumors · 2019 · 6 (3-4) · 57-63

DOI: 10.1159/000501454 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Gastrointestinal Tumors, online erschienen am 31.07.2019. Verfasst von Refik Bademci und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Colorectal Surgery, Department of Surgery, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The prognosis for patients with colorectal cancer shows variation. The characteristics of colorectal cancer patients with signet-ring cell carcinoma (SRCC) are still not clear. Materials and Methods: A retrospective comparison was made of the data of signet-ring cell colorectal carcinoma patients operated on between 2009 and 2018 in respect of clinicopathological and operative results, morbidity, mortality, and long-term survival.

Results

The study included a total of 34 patients comprising 26 (76%) males and 8 (24%) females with a mean age of 58 ± 11.7 years. Incidence of SRCC was determined as 1.8%. Lymphovascular invasion was determined in 22 (64%) patients. Tumors were determined as stage T2 in 8 (32%) patients, stage T3 in 9 (36%), and stage T4 in 8 (32%). According to the TNM classification, 5 (14.7%) patients were diagnosed with stage 1, 7 (20.6%) with stage 2, 15 (44.1%) with stage 3, and 7 (20.6%) with stage 4. The mean follow-up period was 40.6 ± 30.4 months, and mean disease-free follow-up was determined as 33.1 ± 36.1 months. Fifteen (44.1%) patients died because of the disease.

Conclusion

Although SRCC is a poor prognostic factor, it should be kept in mind when determining adjuvant therapies and prognosis of patients determined with advanced-stage SRCC.

Schlagwörter

Stichwörter der Autor:innen

Colorectal carcinomaPrognosisSignet-ring cell carcinoma

Autor:innen und Institutionen

  • Division of Colorectal Surgery, Department of Surgery, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.

Zitieren

APA

Bademci, R., Bollo, J., Martinez, M. C., Hernadez, M. P., & Targarona, E. M. (2019). Colorectal Cancer Prognosis: The Impact of Signet Ring Cell. Gastrointestinal Tumors, 6(3-4), 57-63. https://doi.org/10.1159/000501454

Vancouver

Bademci R, Bollo J, Martinez MC, Hernadez MP, Targarona EM. Colorectal Cancer Prognosis: The Impact of Signet Ring Cell. Gastrointestinal Tumors. 2019;6(3-4):57-63. doi:10.1159/000501454

BibTeX
@article{Bademci2019,
  author = {Bademci, Refik and Bollo, Jesus and Martinez, M Carmen and Hernadez, Maria Pilar and Targarona, Eduardo Maria},
  title = {Colorectal Cancer Prognosis: The Impact of Signet Ring Cell},
  journal = {Gastrointestinal Tumors},
  year = {2019},
  volume = {6},
  number = {3-4},
  pages = {57--63},
  doi = {10.1159/000501454}
}
Kostenlos starten →